SurePulse Medical Ltd, a medical device company based in Nottingham, U.K., has announced today that it has received US FDA 510(k) clearance for its SurePulse VS Newborn Heart Rate Monitor.

The wireless SurePulse VS is specifically designed to be used straight after birth in vulnerable newborn babies. The aim of the heart rate monitor is to give clinicians the right information at the right time to guide optimal neonatal care, something that existing technologies struggle with in this population. The device offers new possibilities in patient care. In addition to enhancing the life chances for newborn babies (and optimising newborn care), the wireless capabilities allows for placement flexibility and easier parent bonding with the newborn baby. It has a touchscreen interface which facilitates event recording for audit, training and governance. The single-use cap, which integrates an optical sensor, is thermally protective and provides attachments for breathing apparatus.

James Carpenter, CEO of SurePulse, said “Our vision is to revolutionize neonatal vital sign monitoring and give clinicians the tools to provide optimal newborn care. We are thrilled to have achieved this important milestone on this journey as the US is a key market for growth, with nearly 400,000 premature births a year. Historically, neonatal care has been significantly underserved with little investment in new technologies, and so this is a real win for clinicians, babies and their parents. SurePulse VS has been designed from the ground up with the baby firmly in mind.”

About SurePulse

SurePulse Medical Ltd is a joint venture between the University of Nottingham (UoN) and Tioga Ltd, a spin-out of the UoN Faculties of Engineering and Medicine. The company has developed and patented technology for monitoring the vital signs of newborn babies. The company has won multiple awards (Medilink East Midlands Startup of the Year 2018 and Innovation Award 2019) recognising the achievements of its 16-strong team of engineering, clinical, commercial and operational excellence.

Latest Opportunities

Calling Supply Chain Innovators: Grants of £100,000 Available!

Funding call for supply chain innovators for grants of up to £100,000 As a Research…

Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices

Summary This consultation invites views on proposals for recognising CE marked medical devices in Great Britain.…

Mental Health First Aid training offer for the Medilink Midlands network

What Red Umbrella offer With tailored delivery and expert integration, every Red Umbrella engagement is…

Latest News

Anglia Ruskin University - Patron Spotlight

Medilink Midlands offers Patronage to leading organisations that champion the medtech and life sciences sector. …

HORIBA to Build a New Global Headquarters

Advancing global operations and realigning domestic sites to strengthen the organisation and lay the groundwork…

MHRA launches a consultation on indefinite recognition of CE-marked medical devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a consultation on proposals for indefinite recognition…

Your innovation deserves recognition

The Medilink Midlands Awards are now open, celebrating outstanding innovation across the region’s medtech and life sciences sector.

With 10 categories to enter, now’s the time to showcase your achievements.
Extended Deadline Date: 16th January

Start your application today.

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​